Substituted 1-alkylcinnolin-4(1H)-one derivatives, preparation thereof and therapeutic application of same
    2.
    发明授权
    Substituted 1-alkylcinnolin-4(1H)-one derivatives, preparation thereof and therapeutic application of same 有权
    取代的1-烷基噌啉-4(1H) - 酮衍生物,其制备方法及其治疗应用

    公开(公告)号:US08420651B2

    公开(公告)日:2013-04-16

    申请号:US13262869

    申请日:2010-04-06

    CPC classification number: C07D237/28

    Abstract: The subject of the present invention is compounds corresponding to the formula (I) in which: X represents a divalent (C2-C5)alkylene radical which is unsubstituted or substituted one or more times by an Alk group; R1 represents a phenyl, a naphthyl, a pyridyl, a 1-benzothienyl or a 1,3-benzodioxolyl; R2 represents a hydrogen atom, a halogen atom, an Alk group, an OAlk group or else a group chosen from —S-Alk, —SO-Alk, —SO2-Alk, —CO—N(R4)-Alk, —N(R4)SO2-Alk, —N(R4)CO-Alk, —N(R4)SO2—N(Alk)2; R3 represents a hydrogen atom, a halogen atom, an Alk group or an OAlk group; R4 represents a hydrogen atom or a (C1-C4)alkyl; Alk represents an unsubstituted or substituted (C1-C4)alkyl. Preparation process and therapeutic application.

    Abstract translation: 本发明的主题是对应于式(I)的化合物,其中:X表示未被取代或被Alk基取代一次或多次的二价(C 2 -C 5)亚烷基; R 1表示苯基,萘基,吡啶基,1-苯并噻吩基或1,3-苯并二恶唑基; R 2表示氢原子,卤素原子,Alk基团,OAlk基团或选自-S-Alk,-SO-Alk,-SO 2 -Alk,-CO-N(R 4)-Alk,-N (R4)SO2-Alk,-N(R4)CO-Alk,-N(R4)SO2-N(Alk)2; R 3表示氢原子,卤素原子,Alk基团或OAlk基团; R4表示氢原子或(C1-C4)烷基; Alk表示未取代或取代的(C1-C4)烷基。 制备工艺及治疗应用。

    SUBSTITUTED 1-ALKYLCINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION OF SAME
    3.
    发明申请
    SUBSTITUTED 1-ALKYLCINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION OF SAME 有权
    取代的1-烷基喹啉-4-(1H) - 酮衍生物,其制备方法及其相应的应用

    公开(公告)号:US20120129864A1

    公开(公告)日:2012-05-24

    申请号:US13262869

    申请日:2010-04-06

    CPC classification number: C07D237/28

    Abstract: The subject of the present invention is compounds corresponding to the formula (I) in which: X represents a divalent (C2-C5)alkylene radical which is unsubstituted or substituted one or more times by an Alk group; R1 represents a phenyl, a naphthyl, a pyridyl, a 1-benzothienyl or a 1,3-benzodioxolyl; R2 represents a hydrogen atom, a halogen atom, an Alk group, an OAlk group or else a group chosen from —S-Alk, —SO-Alk, —SO2-Alk, —CO—N(R4)-Alk, —N(R4)SO2-Alk, —N(R4)CO-Alk, —N(R4)SO2—N(Alk)2; R3 represents a hydrogen atom, a halogen atom, an Alk group or an OAlk group; R4 represents a hydrogen atom or a (C1-C4)alkyl; Alk represents an unsubstituted or substituted (C1-C4)alkyl. Preparation process and therapeutic application.

    Abstract translation: 本发明的主题是对应于式(I)的化合物,其中:X表示未被取代或被Alk基取代一次或多次的二价(C 2 -C 5)亚烷基; R 1表示苯基,萘基,吡啶基,1-苯并噻吩基或1,3-苯并二恶唑基; R 2表示氢原子,卤素原子,Alk基团,OAlk基团或选自-S-Alk,-SO-Alk,-SO 2 -Alk,-CO-N(R 4)-Alk,-N (R4)SO2-Alk,-N(R4)CO-Alk,-N(R4)SO2-N(Alk)2; R 3表示氢原子,卤素原子,Alk基团或OAlk基团; R4表示氢原子或(C1-C4)烷基; Alk表示未取代或取代的(C1-C4)烷基。 制备工艺及治疗应用。

Patent Agency Ranking